Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

Games Workshop shares soar after guidance upgrade

(Sharecast News) - Shares in Games Workshop surged on Wednesday after the Warhammer maker lifted guidance for the full year.

In a typically short statement, the company said trading in January and February had been ahead of expectations, with strong trading across both the core business and licensing. No further details were given.

Games Workshop shares topped the UK's FTSE 100, gaining 7%. The group joined the FTSE 100 at the end of last year boosted by the popularity of the Warhammer hobby, an Amazon Prime TV series and branded video game royalties.

It now expects pre-tax profits to come in ahead of expectations in the year to 1 June. The shares are up almost 60% over the last year.

"In a world full of uncertainty around economics, politics and consumer and business confidence, it's refreshing to see a company be able to get on with the job of making money. Games Workshop is showing resilience in the face of a difficult market backdrop and it's impressive how it has prospered this year," said AJ Bell investment director Russ Mould.

"Games Workshop's recent promotion to the FTSE 100 puts pressure on management to keep delivering good news. They will want to show the world that its inclusion in the premium UK index is not a brief visit and that the business has what it takes to stay in the top league.

"The licencing of its intellectual property is being done under a watchful eye and only the most promising ideas are getting the green light. This quality control might mean it misses out on some potential income, but Games Workshop wants to uphold its brand values and ensure that its reputation isn't tarnished by going down the Disney route of milking assets until they are bone dry."

Reporting by Frank Prenesti for Sharecast.com

Share this article

Related Sharecast Articles

GSK gets preliminary nod for two respiratory drugs in Europe
(Sharecast News) - GSK said on Friday afternoon that two of its respiratory medicines had received positive opinions from the European Medicines Agency's Committee for Medicinal Products for Human Use, bringing the company closer to potential approvals across severe asthma, chronic rhinosinusitis with nasal polyps and chronic obstructive pulmonary disease.
Shore Capital hails improved US biotech funding environment for hVIVO
(Sharecast News) - Shares in AIM-listed hVIVO were continuing their recent surge on the back of encouraging signs from the US biotech market, which broker Shore Capital said has created a "much more favourable environment" for the company.
Weir to buy remaining 50% stake in Chile JV ESEL for £56m
(Sharecast News) - Weir said on Friday that it has agreed to buy the remaining 50% share of its Chile-based joint venture ESEL for a sterling equivalent purchase price of £56m.
Jefferies downgrades Whitbread, upgrades IHG
(Sharecast News) - Jefferies downgraded Whitbread to 'hold' from 'buy' on Friday as it applied the reverse upgrade to InterContinental Hotels.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.